If You Invested $10,000 in CRISPR Therapeutics in 2019, This Is How Much You Would Have Today

Companies in the biotech industry are often capable of delivering explosive returns, especially those with a knack for innovation and breaking new ground. That describes CRISPR Therapeutics (NASDAQ: CRSP) pretty well. The company specializes in gene editing and has made significant progress in the field in recent years.

CRISPR's efforts have been rewarded. The biotech has generally delivered solid returns. Just how good has its stock-market performance been? Let's find out how much a $10,000 investment in the company would be worth today.